Endogenous Antinociceptive Ligands 495 Drew GM, Siddall PJ, Duggan AW (2004) Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 109:379–388 Duarte IDG, Dos Santos IR, Lorenzetti BB, Ferreira SH (1992) Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 217:225–227 Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8:1093–1108 Dubois A, Savasta M, Curet O, Scatton B (1986) Autoradiographic distribution of the D1 agonist [H-3] Skf 38393, in the rat-brain and spinal cord - comparison with the distribution of D2 dopamine-receptors. Neuroscience 19:125–137 Dubuc I, Sarret P, Labbe-Jullie C, Botto JM, Honore E, Bourdel E, Martinez J, Costentin J, Vincent JP, Kitabgi P, Mazella J (1999) Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci 19:503–510 Dumont Y, Martel J-C, Fournier A, St-Pierre S, Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38:125–167 Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V (2004) Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB(2)G(i/o) linked receptor. Br J Pharmacol 142:509–518 Duttaroy A, Gomeza J, Gan J-W, Siddiqui N, Basile AS, Harman D, Smith PL, Felder CC, Levey AI, Wess J (2002) Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62:1084–1093 Dworkin RH (1994) Pain insensitivity in schizophrenia : a neglected phenomenon and some implications. Schizophr Bull 20:235–248 Eaton MJ, Blits B, Ruitenberg MJ, Verhaagen J, Oudega M (2002) Amelioration of chronic neuro- pathic pain after nerve injury by adeno-associated viral (AAV) vector-mediated overexpresion of BDNF in the rat spinal cord. Gene Ther 9:1387–1395 Eaton MJ, Karmally S, Martinez MA, Plunkett JA, Lopez T, Cejas PJ (1999) Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. J Peripher Nerv Syst 4:245–257 Egan TM, Henderson G, North RA, Williams JT (1983) Noradrenaline-mediated synaptic inhibi- tion in rat locus coeruleus neurones. J Physiol (Lond) 345:477–488 Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N, Urade Y, Ito S, Hayaishi O (1999) Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase- deficient mice. Proc Natl Acad Sci U S A 96:726–730 Eisenach JC, De Kock M, Klimscha W (1996a) Alpha2-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984–1995). Anesthesiology 85:655–674 Eisenach JC, Detweiler DJ, Tong C, D’Angelo R, Hood DD (1996b) Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 82: 621–626 Eisenach JC, Gebhart GF (1995) Intrathecal amitriptyline - antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine and carbamylcholine in rats. Anesthesiology 83:1036–1045 Eisenach JC, Hood DD, Curry R (2002) Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 96:29–34 El Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S, Arbid MS (2002) Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res 46: 235–243 Ellington HC, Cotter MA, Cameron NA, Ross RA (2002) The effect of cannabinoids on capsaicin- evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 42:966–975 Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A, Schafer M, Stein C, Zollner C (2007) Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 496 G. Horvath (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 71:12–18 Engstrom M, Brandt A, Wurster S, Savola JM, Panula P (2003) Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J Pharmacol Exp Ther 305:825–832 Enna SJ, McCarson KE (2006) The role of GABA in the mediation and perception of pain. Adv Pharmacol 54:1–27 Faber ESL, Chamber JP, Evans RH (1998) Depression of NMDA receptor-mediated synaptic trans- mission by four alpha2-adrenoceptor agonists on the in vitro rat spinal cord preparation. Br J Pharmacol 124:507–512 Fairbanks CA, Schreiber KL, Brewer KL, Yu C-G, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL (2000) Agmatine reverses pain induced by inflammation, neuropathy and spinal cord injury. Proc Natl Acad Sci U S A 97:10584–10589 Farrell EK, Merkler DJ (2008) Biosynthesis, degradation and pharmacological importance of the fatty acid amides. Drug Discov Today 13:558–568 Farzin D, Asghari L, Nowrouzi M (2002) Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists. Pharmacol Biochem Behav 72:751–760 Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS (2001) Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299:332–342 Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237–246 Ferreira SH, Cunha FQ, Lorenzetti BB, Michelin MA, Perretti M, Flower RJ, Poole S (1997) Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol 121:883–888 Ferreira SH, Duarte IDG, Lorenzetti BB (1991) The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 201:121–122 Ferreira SH, Lorenzetti BB, Faccioli LH (1992) Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin. Eur J Pharmacol 217:207–209 Fields H (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5:565–575 Fields HL, Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In: Wall, PD Melzack, R(eds) Textbook of pain, 4th edn. Churchill Livingstone, Edinburgh, pp 309–329 Fields HL, Heinricher MM, Mason P (1991) Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14:219–245 Finnegan TF, Chen SR, Pan HL (2005) Effect of the mu opioid on excitatory and inhibitory synap- tic inputs to periaqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther 312:441–448 Finnegan TF, Chen SR, Pan HL (2006) Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels. J. Neurophysiol 95:2032–2041 Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, Ogarra A (1991) Il-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822 Fleetwood-Walker SM, Hope PJ, Mitchell R (1988) Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurons. J Physiol 399:335–348 Frances B, Lahlou H, Zajac J-M (2001) Cholera and pertussis toxin inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Regul Pept 98:13–18 Franek M, Vaculin S, Rokyta R (2004) GABA(B) receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol Res 53:351–355 Fredholm BB, IJzerman AP, Jacobson KA, Klotz K-N, Linden J (2001) International union of pharmacology. XXV. nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552 Frizzo ME, Antunes Soares FA, Dall’Onder LP, Lara DR, Swanson RA, Souza DO (2003) Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res 972:84–89 Endogenous Antinociceptive Ligands 497 Fromm C, DeLeo J, Coombs DW, Colburn RW, Twitchell BB (1993) The ganglioside GM1 decrease autotomy but not substance P depletion in a peripheral mononeuropathy rat model. Anesth Analg 77:501–506 Fu CY, Zhao YL, Dong L, Chen Q, Ni JM, Wang R (2008) In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4–11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain Behav Immun 22:850–860 Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, De Fonseca FR, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425:90–93 Fuji K, Senba E, Ueda Y, Tohyama M (1983) Vasoactive intestinal polipeptide /VIP/-containing neurons in the spinal cord of the rat and their projections. Neurosci Lett 37:51–55 Fujimoto J, Arts KS, Rady J, Tseng L (1990) Intracerebroventricular analgesia enhanced by intrathecal (IT) dynorphin A (1–17) antibody. Prog Clin Biol Res 328:433–436 Fukui M, Nakagawa T, Minami M, Satoh M (2001) Antinociceptive effects of intracerebroventric- ularly administered P2 purinoceptor agonists in the rat. Eur J Pharmacol 419:25–31 Fukui M, Nakagawa T, Minami M, Satoh M, Kaneko S (2006) Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats. Mol Pain 2:19 Fukui M, Takishita A, Zhang NN, Nakagawa T, Minami M, Satoh M (2004) Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by alpha,beta-methylene-ATP in rats. J Pharmacol Sci 94:153–160 Fukusumi S, Fujii R, Hinuma S (2006) Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 27:1073–1086 Furst S (1999) Transmitters involved in antinociception in the spinal cord. Brain Res Bull 48: 129–141 Gagnier JJ (2001) The therapeutic potential of melatonin in migraines and other headaches types. Altern Med Rev 6:383–389 Gamse R, Leeman SE, Holzer P, Lembeck F (1981) Differential effects of capsaicin on the con- tent of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 317:140–148 Ganong AH, Lanthorn TH, Cotman CW (1983) Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res 273: 170–174 Gao L, Yu LC (2004) Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats. Regul Pept 120:53–58 Gardell LR, Ibrahim M, Wang R, Wang Z, Ossipov MH, Malan TP Jr, Porreca F, Lai J (2004) Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain. Neuroscience 123:43–52 Garraway SM, Anderson AJ, Mendell LM (2005) BDNF-induced facilitation of afferent-evoked responses in lamina II neurons is reduced after neonatal spinal cord contusion injury. J Neurophysiol 94:1798–1804 Gauldie SD, McQueen DS, Pertwee R, Chessell IP (2001) Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br J Pharmacol 132:617–621 Gaumann DM, Brunet PC, Jirounek P (1992) Clonidine enhances the effects of lidocaine on C-fiber action potential. Anesth Analg 74:719–725 Gear RW, Aley KO, Levine JD (1999) Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19:7175–7181 Genzen JR, McGehee DS (2005) Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res 1031:229–237 Gerevich Z, Borvendeg SJ, Schroder W, Franke H, Wirkner K, Norenberg W, Furst S, Gillen C, Illes P (2004) Inhibition of N-type voltage-activated calcium channels in rat dorsal root gan- glion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 24:797–807 Gerevich Z, Illes P (2004) P2Y receptors and pain transmission. Purinergic Signal 1:3–10 498 G. Horvath Gergen KA, Zadina JE, Kastin AJ, Paul D (1996) Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors. Eur J Pharmacol 298: 235–239 Gibbs JL, Flores CM, Hargreaves KM (2006a) Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain 124:167–174 Gibbs JL, Hargreaves KM (2008) Neuropeptide Y Y1 receptor effects on pulpal nociceptors. J Dent Res 87:948–952 Gibbs TT, Russek SJ, Farb DH (2006b) Sulfated steroids as endogenous neuromodulators. Pharmacol Biochem Behav 84:555–567 Gibson DA, Harris BR, Rogers DT, Littleton JM (2002) Radioligand binding studies reveal agma- tine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res 952:71–77 Gilbert AK, Franklin KBJ (2001) GABAergic modulation of descending inhibitory systems from the rostral ventromedial medulla (RVM). Dose-response analysis of nociception and neurological deficits. Pain 90:25–36 Gilbert SD, Clark TM, Flores CM (2001) Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 89:159–165 Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683 Giordano J, Rogers L (1989) Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 170:83–86 Glick SD, Crane LA (1978) Opiate-like and abstinence-like effects of intracerebral histamine administration in rats. Nature 273:547–549 Goettl VM, Lindsey AE, Neff NH, Hadjiconstantinou M (2000) GM1 ganglioside restores abnor- mal responses to acute thermal and mechanical stimuli in aged rats. Brain Res 858:380–385 Gomes JA, Li X, Pan H-L, Eisenach JC (1999) Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology 91: 1072–1079 Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J (1999a) Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 96:1692–1697 Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C-X, Wess J (1999b) Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M 4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 96:10483–10488 Gouarderes C, Sutak M, Zajac J-M, Jhamandas K (2000) Role of adenosine in the spinal antinoci- ceptive and morphine modulatory actions of neuropeptide FF analogs. Eur J Pharmacol 406:391–401 Goudet C, Chapuy E, Alloui A, Acher F, Pin JP, Eschalier A (2008) Group III metabotropic glu- tamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain. Pain 137:112–124 Grass S, Crawley JN, Xu XJ, Wiesenfeld-Hallin Z (2003a) Reduced spinal cord sensitization to C-fibre stimulation in mice over-expressing galanin. Eur J Neurosci 17:1829–1832 Grass S, Jacoby AS, Iismaa TP, Crawley JN, Xu X-J, Wiesenfeld-Hallin Z (2003b) Flexor reflex excitability in mice lacking galanin receptor galanin-R1. Neurosci Lett 345:153–156 Grazia Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V (2004) A structure- activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314:192–196 Green PG, Strausbaugh HJ, Levine JD (1998) Annexin 1 is a local mediator in neural-endocrine feedback control of inflammation. J Neurophysiol 80:3120–3126 Grill M, Heinemann A, Hoefler G, Peskar BA, Schuligoi R (2008) Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD(2) receptors. J Neurochem 104:1345–1357 Endogenous Antinociceptive Ligands 499 Guan Y, Terayama R, Dubner R, Ren K (2002) Plasticity in excitatory amino acid receptor- mediated descending pain modulation after inflammation. J Pharmacol Exp Ther 300:513–520 Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L (1997) Stress- induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 9:271–279 Gui X, Carraway RE, Dobner PR (2004) Endogenous neurotensin facilitates visceral nocicep- tion and is required for stress-induced antinociception in mice and rats. Neuroscience 126: 1023–1032 Guimaraes AP, Guimaraes FS, Prado WA (2000) Modulation of carbachol-induced antinociception from the rat periaqueductal gray. Brain Res Bull 51:471–478 Guindon J, Desroches J, Beaulieu P (2007) The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. Br J Pharmacol 150: 693–701 Guindon J, Hohmann AG (2007) Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153:319–334 Guindon J, Lo Verme J, De Lean A, Piomelli D, Beaulieu P (2006a) Synergistic antinocicep- tive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? Eur J Pharmacol 550:68–77 Guindon J, De Lean A, Beaulieu P (2006b) Local interactions between anandamide, an endo- cannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain 121:85–93 Guitart X, Codony X, Monroy X (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology 174:301–319 Gulati A, Srimal RC (1992) Endothelin mechanisms in the central nervous system: a target for drug development. Drug Dev Res 26:361–387 Guneli E, Kazikdas KC, Kolatan E (2007) Ghrelin may attenuate proinflammatory cytokine- mediated neuropathic pain. Med Hypotheses 69:356–360 Guo H, Zhao Z-Q (2000) Inhibition of nociceptive withdrawal reflex by microinjection of interleukin 2 into rat locus coeruleus. Neuropeptides 34:216–220 Guo TZ, Jiang JY, Buttermann AE, Maze M (1996) Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 84:873–881 Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121–130 Haberberger RV, Bernardini N, Kress M, Hartmann P, Lips KS, Kummer W (2004) Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Auton Neurosci 113:32–42 Hajos M, Engberg G (1990) Kynurenic acid blocks chemogenic nociception. J Pharm Pharmacol 42:373–374 Hajos M, Jancso G, Engberg G (1987) Capsaicin-induced excitation of locus coeruleus neurons. Acta Physiol Scand 129:415–420 Hamon M, Bourgoin S (1999) Serotonin and its receptors in pain control. In: Sawynok, J Cowan, A (eds) Novel aspects of pain management: opioids and beyond. Wiley-Liss Inc, New York, NY, pp 203–228 Hansen HS, Artmann A (2008) Endocannabinoids and nutrition. J Neuroendocrinol 20:94–99 Hansson HA, Rozell B, Skottner A (1987) Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve af adult rats. Cell Tissue Res 247:241–247 Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A 98:3662–3665 Hao SL, Takahata O, Iwasaki H (1999) Isobolographic analysis of interaction between spinal endomorphin-1, a newly isolated endogenous opioid peptide, and lidocaine in the rat formalin test. Neurosci Lett 276:177–180 500 G. Horvath Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflam- matory effects of interleukin-4 - suppression of human monocyte tumor necrosis factor-alpha, interleukin-1, and prostaglandin-E2. Proc Natl Acad Sci U S A 86:3803–3807 Harte SE, Hoot MR, Borszcz GS (2004) Involvement of the intralaminar parafascicular nucleus in muscarinic-induced antinociception in rats. Brain Res 1019:152–161 Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, Wolfer DP, Betz H, Zeilhofer HU, Muller U (2004) GlyR alpha 3: an essential target for spinal PGE(2)-mediated inflammatory pain sensitization. Science 304:884–887 Harvey S, Hayer S (1993) Parathyroid hormone binding sites in the brain. Peptides 14:1187–1191 Hata AN, Zent R, Breyer MD, Breyer RM (2003) Expression and molecular pharmacology of the mouse CRTH2 receptor. J Pharmacol Exp Ther 306:463–470 Haulica I, Neamtu C, Stratone A, Petrescu G, Branisteanu D, Rosca V, Slatineanu S (1986) Evidence for the involvement of cerebral renin-angiotensin system (RAS) in stress analgesia. Pain 27:237–245 Haws CM, Heinricher MM, Fields HL (1990) Alpha-adrenergic receptor agonists, but not antag- onists, alter the tail-flick latency when microinjected into the rostral ventromedial medulla of the lightly anesthetized rat. Brain Res 533:192–195 Hayes RL, Mao J, Price DD, Germano A, D’Avella D, Fiori M, Mayer DJ (1992) Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral neuropathy. Pain 48:391–396 Heimann AS, Gomes L, Dale CS, Pagano RL, Gupta A, de Souza LL, Luchessi AD, Castro LM, Giorgi R, Rioli V, Ferro ES, Devi LA (2007) Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A 104:20588–20593 Heinricher MM, McGaraughty S (1998) Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75:247–255 Heinricher MM, McGaraughty S, Farr DA (1999) The role of excitatory amino acid transmis- sion within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81:57–65 Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L (2006) Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharmacol 69:991–997 Helyes Z, Pozsgai G, Borzsei R, Nemeth J, Bagoly T, Mark L, Pinter E, Toth G, Elekes K, Szolcsanyi J, Reglodi D (2007) Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. Peptides 28:1847–1855 Helyes Z, Than M, Oroszi G, Pinter E, Nemeth J, Keri S, Szolcsanyi J (2000) Anti-nociceptive effect induced by somatostatin released from sensory nerve teminals and by synthetic somato- statin analogues in the rat. Neurosci Lett 278:185–188 Hermanns H, Muth-Selbach U, Williams R, Krug S, Lipfert P, Werdehausen R, Braun S, Bauer I (2008) Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain. Neurosci Lett 445:214–219 Hernandez-Pacheco A, Araiza-Saldana CI, Granados-Soto V, Mixcoatl-Zecuatl T (2008) Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin. Eur J Pharmacol 596:70–76 Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 12: 7463–7473 Hobson SA, Holmes FE, Kerr NCH, Pope RJP, Wynick D (2006) Mice deficient for galanin recep- tor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J Neurochem 99:1000–1010 Hohmann AG (2002) Spinal and peripheral mechanisms of cannabinoid antinociception: behav- ioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121:173–190 Endogenous Antinociceptive Ligands 501 Hohmann AG (2007) Inhibitors of monoacylglycerol lipase as novel analgesics. Br J Pharmacol 150:673–675 Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) An enocannabinoid mechanism for stress-induced analgesia. Nature 435:1108–1112 Holden JE, Pizzi JA (2008) Lateral hypothalamic-induced antinociception may be mediated by a substance P connection with the rostral ventromedial medulla. Brain Res 1214:40–49 Holden JE, Van Poppel AY, Thomas S (2002) Antinociception from lateral hypothalamic stimula- tion may be mediated by NK(1) receptors in the A7 catecholamine cell group in rat. Brain Res 953:195–204 Holland PR, Akerman S, Goadsby PJ (2005) Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 315:1380–1385 Holmberg K, Kuteeva E, Brumovsky P, Kahl U, Karlstrom H, Lucas GA, Rodriguez J, Westerblad H, Hilke S, Theodorsson E, Berge OG, Lendahl U, Bartfai T, Hokfelt T (2005) Generation and phenotypic characterization of a galanin overexpressing mouse. Neuroscience 133:59–77 Holmes C, Landry D, Granton J (2003) Science review: vasopressin and the cardiovascular system part 1 - receptor physiology. Crit Care 7:427–434 Holmes FE, Arnott N, Vanderplank PA, Kerr NCH, Longbrake EE, Popovich PG, Imai T, Combadiere C, Murphy PM, Wynick D (2008) Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem 106:640–649 Honda M, Okutsu H, Matsuura T, Miyagi T, Yamamoto Y, Hazato T, Ono H (2001) Spinorphin, and endogenous inhibitor of enkephalin-degrading enzymes, potentiates Leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Jpn J Pharmacol 87:261–267 Honda M, Uchida K, Tanabe M, Ono H (2006) Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors. Neuropharmacology 51:866–872 Hood DD, Mallak KA, James RL, Tuttle R, Eisenach JC (1997) Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 282:86–92 Hornfeldt CS, Smullin DH, Schamber CD, Sun X, Larson AA (1992) Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sci 50:1925–1934 Horvath G (2000) Endomorphin-1 and endomorphin-2. Pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther 88:437–463 Horvath G, Agil A, Joo G, Dobos I, Benedek G, Baeyens JM (2003) Evaluation of endomorphin- 1ontheactivityofNa + ,K + -ATPase using in vitro and in vivo studies. Eur J Pharmacol 458: 291–297 Horvath G, Farkas I, Tuboly G, Benedek G (2008a) The antinociceptive effects of intrathecal injection of N-arachidonoyl-dopamine (NADA) are mediated by cannabinoid receptors. Clin Neorosci 61(S1):44–45 Horvath G, Kekesi G (2006) Interaction of endogenous ligands mediating antinociception. Brain Res Rev 52:69–92 Horvath G, Kekesi G, Tuboly G, Benedek G (2007) Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level. Brain Res 1155:42–48 Horvath G, Kovacs M, Szikszay M, Benedek G (1994) Mydriatic and antinociceptive effects of intrathecal dexmedetomidine in conscious rats. Eur J Pharmacol 253:61–66 Horvath G, Szikszay M, Tomboly C, Benedek G (1999) Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats. Life Sci 65:2635–2641 Horvath G, Kekesi G, Nagy E, Benedek G (2008b) The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain 134:277–284 Hou S-W, Qi J-S, Zhang Y, Qiao J-T (2003) Spinal antinociceptive effect of agmatine and tenta- tive analysis of involved receptors: study in an electrophysiological model of rats. Brain Res 968:277–280 502 G. Horvath Houghton LA, Lea R, Jackson N, Whorwell PJ (2002) The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 50:471–474 Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47:345–358 Hu LF, Wong PTH, Moore PK, Bian JS (2007) Hydrogen sulfide attenuates lipopolysaccharide- induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100:1121–1128 Hua X-Y, Boublik JH, Spicer MA, Rivier JE, Brown MR, Yaksh TL (1991) The antinoci- ceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther 258:243–248 Hua XY, Hayes CS, Hofer A, Fitzsimmons B, Kilk K, Langel U, Bartfai T, Yaksh TL (2004) Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. J Pharmacol Exp Ther 308:574–582 Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642 Huang J, Wang YY, Wang W, Li YQ, Tamamaki N, Wu SX (2008) 5-HT3A receptor subunit is expressed in a subpopulation of GABAergic and enkephalinergic neurons in the mouse dorsal spinal cord. Neurosci Lett 441:1–6 Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, Burstein S, Di Marzo V, Walker JM (2001) Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276:42639–42644 Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A 99:8400–8405 Hucho TB, Dina OA, Kuhn J, Levine JD (2006) Estrogen controls PKC epsilon-dependent mechan- ical hyperalgesia through direct action on nociceptive neurons. Eur J Neurosci 24:527–534 Hughes J, Smith TW, Kosterlitz HW (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577–579 Hunter JC, Atwal P, Woodruff GN, Singh L (1994) Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine. Br J Pharmacol 112: 1002–1003 Hurley RW, Banfor P, Hammond DL (2003) Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience 118:789–796 Hussey MJ, Clarke GD, Ledent C, Hourani SMO, Kitchen I (2007) Reduced response to the for- malin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice. Pain 129:287–294 Hwang JH, Yaksh TL (1997) The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain 70:15–22 Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 102:3093–3098 Illes P, Finta EP, Nieber K (1993) Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus cooeruleus neurones. Naunyn Schmiedebergs Arch Pharmacol 348:546–548 Inoue K, Tsuda M, Tozaki-Saitoh H (2007) Modification of neuropathic pain sensation through microglial ATP receptors. Purinergic Signal 3:311–316 Inoue M, Kawashima T, Allen RG, Ueda H (2003) Nocistatin and prepro-nociceptin/orphanin FQ 160–187 cause nociception through activation of G i/o in capsaicin-sensitive and Endogenous Antinociceptive Ligands 503 of G s in capsaicin-insensitive nociceptors, respectively. J Pharmacol Exp Ther 306: 141–146 Inoue M, Nakayamada H, Tokuyama S, Ueda H (1997) Peripheral non-opioid analgesic effects of kyotorphin in mice. Neurosci Lett 236:60–62 Inoue N, Hatanaka H (1982) Nerve growth factor induces specific enkephalin binding sites in a nerve cell line. J Biol Chem 257:9238–9241 Intondi AB, Dahlgren MN, Eilers MA, Taylor BK (2008) Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain. Pain 137: 352–365 Ishikawa T, Marsala M, Sakabe T, Yaksh TL (2000) Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA A receptor antagonist. Neuroscience 95:781–786 Issa PC, Lever IJ, Michael GJ, Bradbury EJ, Malcangio M (2001) Intrathecally delivered glial cell line-derived neurotrophic factor produces electrically evoked release of somatostatin in the dorsal horn of the spinal cord. J Neurochem 78:221–229 Ito K, Yoshikawa M, Maeda M, Jin XL, Takahashi S, Matsuda M, Tamaki R, Kobayashi H, Suzuki T, Hashimoto A (2008) Midazolam attenuates the antinociception induced by D-serine or morphine at the supraspinal level in rats. Eur J Pharmacol 586:139–144 Ito S, Okuda-Ashitaka E, Minami T (2001) Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 41: 299–332 Iwamoto ET, Marion L (1993) Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 266:329–338 Jackson KC, St Onge EL (2003) Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Pract 3:135–143 Jacquet YF (1988) The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Eur J Pharmacol 154:271–276 Jaggar SI, Hasnie FS, Sellaturay S, Rice ASC (1998) The anti-hyperalgesic actions of the cannabi- noid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189–199 Jancso G, Hokfelt T, Lundberg JM, Kiraly E, Halasz N, Nilsson G, Terenius L, Rehfeld J, Steinbusch H, Verhofstad A, Elde R, Said A, Brown M (1981) Immunohistochemical stud- ies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol 10:963–980 Jancso G, Jancso-Gabor A (1980) Effect of capsaicin on morphine analgesia- possible involvement of hypothalamic structures. Naunyn Schmiedebergs Arch Pharmacol 311: 285–288 Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT (2003) Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Neuroscience 23:641–647 Jensen RT, Battey JF, Spindel ER, Benya RV (2008) International Union of Pharmacology. LXVIII. mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1–42 Jensen TS, Yaksh TL (1984) Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res 296:285–293 Jensen TS, Yaksh TL (1989) Comparison of the antinociceptive effect of morphine and gluta- mate at coincidental sites in the periaqueductal gray and medial medulla in rats. Brain Res 476:1–9 Jeong CY, Choi JI, Yoon MH (2004) Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 502:205–211 Ji G, Neugebauer V (2008) Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol 99:1201–1212 504 G. Horvath Ji R, Zhang Q, Bedecs K, Arvidsson J, Zhang X, Xu X, Wiesenfeld-Hallin Z, Bartfai T, Hokfelt T (1994a) Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci U S A 91:12540–12543 Ji RR, Zhang X, Wiesenfeldhallin Z, Hokfelt T (1994b) Expression of neuropeptide Y and neu- ropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci 14:6423–6434 Ji Y, Tang B, Traub RJ (2005) Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain 117:433–442 Jiang CL, Xu D, Lu CL, Wang YX, You ZD, Liu XY (2000a) Interleukin-2: structural and biological relatedness to opioid peptides. Neuroimmunomodulation 8:20–24 Jiang CL, You ZD, Lu CL, Xu D, Wang AJ, Wang YX, Liu XY (2000b) Leu-enkephalin induced by IL-2 administration mediates analgesic effect of IL-2. NeuroReport 11:1483–1485 Jiang P, Yang CX, Wang YT, Xu TL (2006) Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience 141: 2041–2050 Jimenez-Andrade JM, Lundstrom L, Sollenberg UE, Langel U, Castaneda-Hernandez G, Carlton SM (2006) Activation of peripheral galanin receptors: differential effects on nociception. Pharmacol Biochem Behav 85:273–280 Jimenez-Andrade JM, Zhou S, Du J, Yamani A, Grady JJ, Castaneda-Hernandez G, Carlton SM (2004) Pro-nociceptive role of peripheral galanin in inflammatory pain. Pain 110:10–21 Joels M (1997) Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18:2–48 Johansson O, Hokfelt T, Pernow B, Jeffcoate SL, White N, Steinbusch HWM, Verhofstad AAJ, Emson PC, Spindel E (1981) Immunohistochemical support for three putative trans- mitters in one neuron: coexistence of 5-hydroxytryptamine, substance P- and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience 6:1857–1881 Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24:7353–7365 Jones PG, Dunlop J (2007) Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Neuropharmacology 53:197–206 Jongsma H, Pettersson LME, Zhang Y, Reimer MK, Kanje M, Waldenstrom A, Sundler F, Danielsen N (2001a) Markedly reduced chronic nociceptive response in mice lacking the PAC I receptor. NeuroReport 12:2215–2219 Jongsma WH, Danielsen N, Johnson JM, Gratto KA, Karchewski LA, Verge VM (2001b) Exogenous NT-3 and NGF differentially modulate PACAP expression in adult sensory neurons, suggesting distinct roles in injury and inflammation. Eur J Neurosci 14:267–282 Jordan BA, Cvejic S, Devi LA (2000) Opioids and their complicated receptor complex. Neuropsychopharmacology 23:S5–S18 Joseph T, Lee TL, Li C, Siau C, Nishiuchi Y, Kimura T, Tachibana S (2007) Levels of neuropeptides nocistatin, nociceptin/orphanin FQ and their precursor protein in a rat neuropathic pain model. Peptides 28:1433–1440 Kajiyama S, Kawamoto M, Shiraishi S, Gaus S, Matsunaga A, Suyama H, Yuge O (2005) Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats. Brain Res 1044:76–86 Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K, Sideri A, Zouridakis M, Tzartos SJ (2007) Muscle and neuronal nicotinic acetylcholine receptors - Structure, function and pathogenicity. FEBS J 274:3799–3845 Kalliomaki J, Pertovaara A, Brandt A, Wei H, Pietila P, Kalmari J, Xu M, Kalso E, Panula P (2004) Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms. Neuropharmacology 46:412–424 . during acute pain. Anesth Analg 82: 621–626 Eisenach JC, Gebhart GF (1995) Intrathecal amitriptyline - antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine. JM, Wang R (2008) In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4–11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain Behav Immun 22:850–860 Fu. acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res 273: 170–174 Gao L, Yu LC (2004) Involvement of opioid receptors in the oxytocin-induced